S&P 500
5,888.55
-0.6%
-$32.99
DJI
42,098.70
-0.6%
-$244.95
NASDAQ
19,100.94
-0.5%
-$98.23
Bitcoin
108,072.00
-0.7%
-814.29
AAPL
$200.40
+0.1%
+$0.19
AMZN
$204.64
-0.7%
-$1.38
GOOG
$173.28
-0.4%
-$0.70
META
$643.48
+0.2%
+$1.16
MSFT
$457.40
-0.7%
-$3.28
NVDA
$135.14
-0.3%
-$0.36
TSLA
$356.97
-1.6%
-$5.92
Nutra Pharma (OTC: NPHC)
$0.00
(0.0%)
$0.00
Price as of May 21, 2025, 3:02 p.m. ET
Nutra Pharma Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Nutra Pharma Company Info
Nutra Pharma Corp. operates as a bio pharmaceutical company. The firm engages in the acquisition, licensing and commercialization of pharmaceutical products and technologies & homeopathic and ethical drugs for the management of pain, neurological disorders, autoimmune and infectious diseases. Its products are Cobroxin, which is used for an over-the-counter pain reliever designed to treat moderate to severe chronic pain and Nyloxin Extra Strength, which is used for stronger versions of Cobroxin. The company was founded on February 1, 2000 and is headquartered in Plantation, FL.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.